Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
N
Shared by NobleBlocks on Jan 1, 2023 • 12:00 AM UTC
Authors:
Thomas Daix
,
Armelle Mathonnet
,
Scott Brakenridge
Research Assistant
AI chat, annotations, notes & similar papers
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial | NobleBlocks
